François Ravenelle
Fondateur chez Inversago Pharma, Inc.
Profil
François Ravenelle was the founder of Inversago Pharma, Inc. which was founded in 2015, where he held the title of Chief Executive Officer & Director.
He previously worked as Director-Business Development at Labopharm, Inc. from 2002 to 2008, Director-Pharmaceutical Development at Theratechnologies, Inc., and Director-Pharmaceutical Development at Verlyx Pharma, Inc. from 2011 to 2013.
Dr. Ravenelle earned a doctorate degree from McGill University in 2002.
Postes actifs de François Ravenelle
Sociétés | Poste | Début |
---|---|---|
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Fondateur | 01/01/2015 |
Anciens postes connus de François Ravenelle
Sociétés | Poste | Fin |
---|---|---|
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Corporate Officer/Principal | 01/01/2008 |
THERATECHNOLOGIES INC. | Corporate Officer/Principal | - |
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Corporate Officer/Principal | - |
Formation de François Ravenelle
McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
THERATECHNOLOGIES INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
Labopharm, Inc.
Labopharm, Inc. BiotechnologyHealth Technology Labopharm, Inc. discovers and develops drugs. The company was founded in 1990 and is headquartered in Montreal, Canada. | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada. | Health Technology |